Ascent Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Sell |
5,267
-1,492
| -22% | -$580K | 0.08% | 212 |
|
|
2025
Q1 | $2.94M | Buy |
6,759
+501
| +8% | +$218K | 0.13% | 174 |
|
|
2024
Q4 | $2.31M | Buy |
6,258
+102
| +2% | +$37.6K | 0.17% | 149 |
|
|
2024
Q3 | $3.2M | Buy |
6,156
+1,253
| +26% | +$652K | 0.24% | 100 |
|
|
2024
Q2 | $2.66M | Buy |
4,903
+1,138
| +30% | +$617K | 0.22% | 120 |
|
|
2024
Q1 | $1.95M | Buy |
3,765
+2,849
| +311% | +$1.48M | 0.17% | 178 |
|
|
2023
Q4 | $463K | Sell |
916
-18
| -2% | -$9.09K | 0.04% | 359 |
|
|
2023
Q3 | $423K | Sell |
934
-22
| -2% | -$9.97K | 0.05% | 341 |
|
|
2023
Q2 | $442K | Sell |
956
-210
| -18% | -$97.2K | 0.05% | 322 |
|
|
2023
Q1 | $536K | Sell |
1,166
-312
| -21% | -$143K | 0.06% | 305 |
|
|
2022
Q4 | $758K | Sell |
1,478
-25
| -2% | -$12.8K | 0.09% | 248 |
|
|
2022
Q3 | $822K | Buy |
1,503
+734
| +95% | +$401K | 0.1% | 228 |
|
|
2022
Q2 | $367K | Buy |
769
+181
| +31% | +$86.4K | 0.04% | 354 |
|
|
2022
Q1 | $289K | Buy |
+588
| New | +$289K | 0.03% | 393 |
|